Overall, Haemonetics showed a net 5 percent increase in revenues for the year while revenue in the fourth quarter was up 1 percent.
Revenues for the company’s OrthoPAT orthopedic perioperative autotransfusion system disposables were down 4 percent, diagnostics revenue was up 16 percent, and software Solutions revenue was up 86 percent. The company integrated its acquisition of Global Med and significantly enhanced its software products for blood bank and hospital customers.
Equipment and other revenue were up 7 percent and placements of equipment under use plans were strong, with a 7 percent total growth rate among hospitals during FY 2011.
Read the release on Haemonetics Corp.
Related Articles on Blood Products:
Critical Importance of the Perioperative Director to OR Efficiency: Q&A With Dr. Timothy Dowd of North American Partners in Anesthesia
Internal Review at University of New Mexico Health Sciences Center Refutes Surgeon’s Claims of Substandard Care
AANS: 8% of Adult Spinal Surgeries Result in Major Complications
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
